Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations.

Research output: Contribution to journal › Article › peer-review

Standard Standard

Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations. / Hughes, D.; Hughes, D.A.
In: European Journal of Cancer, Vol. 41, No. 11, 01.07.2005, p. 1655.

Research output: Contribution to journal › Article › peer-review

HarvardHarvard

Hughes, D & Hughes, DA 2005, 'Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations.', European Journal of Cancer, vol. 41, no. 11, pp. 1655. https://doi.org/10.1016/j.ejca.2005.02.033

APA

Hughes, D., & Hughes, D. A. (2005). Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations. European Journal of Cancer, 41(11), 1655. https://doi.org/10.1016/j.ejca.2005.02.033

CBE

Hughes D, Hughes DA. 2005. Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations. European Journal of Cancer. 41(11):1655. https://doi.org/10.1016/j.ejca.2005.02.033

MLA

Hughes, D. and D.A. Hughes. "Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations.". European Journal of Cancer. 2005, 41(11). 1655. https://doi.org/10.1016/j.ejca.2005.02.033

VancouverVancouver

Hughes D, Hughes DA. Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations. European Journal of Cancer. 2005 Jul 1;41(11):1655. doi: 10.1016/j.ejca.2005.02.033

Author

Hughes, D. ; Hughes, D.A. / Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations. In: European Journal of Cancer. 2005 ; Vol. 41, No. 11. pp. 1655.

RIS

TY - JOUR

T1 - Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations.

AU - Hughes, D.

AU - Hughes, D.A.

PY - 2005/7/1

Y1 - 2005/7/1

KW - ONCOLOGY

U2 - 10.1016/j.ejca.2005.02.033

DO - 10.1016/j.ejca.2005.02.033

M3 - Article

VL - 41

SP - 1655

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 11

ER -